Hydroxyamfetamine

From Wikipedia, the free encyclopedia
Hydroxyamfetamine
Systematic (IUPAC) name
4-(2-aminopropyl)phenol
Clinical data
Legal status Prescription only
Routes Topical (ocular)
Identifiers
CAS number 1518-86-1
ATC code None
PubChem CID 3651
ChemSpider 3525
ChEMBL CHEMBL1546
Chemical data
Formula C9H13NO 
Mol. mass 151.206 g/mol

Hydroxyamfetamine (INN; brand names Paredrine, Mycadrine, and Pedrolon) or hydroxyamphetamine (USAN, BAN), also known by the names oxamphetamine, norpholedrine, 4-hydroxyamphetamine, para-hydroxyamphetamine, and α-methyltyramine, is a sympathomimetic drug, that is, a drug that stimulates the sympathetic nervous system. When used in eye drops, it dilates the pupil. Hydroxyamfetamine is sold in combination with tropicamide under the brand name Paremyd. It occurs as a metabolite of amphetamine.

Once thought to be a human invention, hydroxyamfetamine is now known to occur as an alkaloid in plants including Acacia berlandieri.[1]

In 1944, the US Naval Submarine Medical Research Laboratory researched the use of Paredrine to improve adaptation to night vision in submarine personnel. A significant improvement in adaptation was shown in the 17 subjects they tested.[2]

See also

References

  1. Shulgin, Alexander (September 26, 2001). "Ask Dr. Shulgin Online: Acacias and Natural Amphetamine". Center for Cognitive Liberty & Ethics. Retrieved 2010-02-18. 
  2. Verplanck, WS (1944). "The effects of paregrine on night vision performance.". US Naval Submarine Medical Research Laboratory Technical Report 42. Retrieved 2010-02-18. 

External links


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.